What US Pharma Lab does

US Pharma Lab (USPL) is a B2B contract developer, manufacturer, and supplier of premium dietary supplement ingredients, founded in 1996 and headquartered in North Brunswick, New Jersey. The company operates a full turnkey model covering formulation development, manufacturing, and packaging for brand clients in the dietary supplement, medical food, and specialty nutrition categories. Since 2023, USPL has functioned as the North American headquarters and manufacturing hub of Italy-based Biofarma Group, giving the company a multi-site parent footprint spanning Italy, France, and the United States.

The technical platform is centered on a broad portfolio of delivery forms — tri-layer and bi-layer tablets, extended/modified-release tablets, chewable and orally dispersible tablets (ODT), hard capsules, bulk and ready-to-drink powders, beadlets (500–2000 µm multiparticulate matrix), and mini-tablets with personalized release profiles — supported by proprietary taste and odor masking systems and a tablet-in-capsule technology. Probiotic manufacturing is operated in a dedicated 25% RH-controlled environment for stability assurance. The facility runs 12 dedicated packaging lines covering bottles, cartons, blister cards, boxes, stick packs, in-line blister printing, and probiotic-specific packaging. Regulatory depth is a defining feature: the company holds FDA Registration (dietary supplements and cosmetics), NSF, NSF GRMA, USP, TGA (Australia), Halal, Kosher, UL (Dietary Supplements and Specialty Dietary Ingredients), EcoCert, and a New Jersey State manufacturing license.

US Pharma Lab operates a pure B2B enterprise sales model targeting dietary supplement brands through direct field engagement. Revenue is generated via custom contract manufacturing services priced on a quote basis, which is not publicly disclosed. Customer logos, contract values, and revenue figures are not disclosed in available sources. Founder Ashok Luhadia is the only named leadership figure; no broader management team, headcount trend, or financial disclosures are available. The company has no disclosed AI/ML capabilities, no API platform, and no app or SDK products — its competitive positioning is grounded in process engineering, dosage-form innovation, regulatory credentials, and parent-group scale rather than software or data assets.

Name

US Pharma Lab

Legal name

US Pharma Lab

Website

https://uspl.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

251–500 employees

Short description

US Pharma Lab is a B2B contract manufacturer of premium dietary supplement ingredients, founded in 1996 in North Brunswick, NJ, and operating since 2023 as the North American hub of Italy's Biofarma Group. It serves supplement brands with turnkey development, probiotic manufacturing, and 12 dedicated packaging lines.

Ownership category

akta.pro rank

Product category

Contract Dietary Supplement Manufacturing

NAICS

Food Manufacturing (311)

SIC

Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090)

akta.pro primary industry

Multivitamins & Daily Packs (CRADAGAC)

akta.pro secondary industries

Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE), Vitamins & Minerals (Single Nutrients) (CRADAGAB), Specialized Dairy Nutrition Base Powder & Premix Manufacturing (Vitamin/Mineral/Functional Premixes) (AFAHAHAJ), Fortification Ingredients (Vitamins, Minerals, Nutrient Premixes) (CRADAOAM)

Keywords

• Contract dietary supplement manufacturing
• Custom tablet development
• Probiotic manufacturing services
• Premix formulations
• Turnkey packaging solutions

Headquarters

HQ city

North Brunswick

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Custom Dietary Supplement Manufacturing: B2B contract manufacturing services for dietary supplement brands, providing custom development, production, and packaging of premium supplement ingredients and finished products in various delivery forms.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

USPL is a custom developer, manufacturer, and supplier of premium dietary supplement ingredients, premixes, and finished products, serving nutraceutical brands across nine dosage formats (tablets, hard capsules, chewable/ODT, powders, beadlets, mini-tablets, probiotics, solid food supplements, and medical foods). The company also offers turnkey packaging solutions designed to address challenges in product formulation and stability for B2B clients.

Product overview

US Pharma Lab is a custom developer, manufacturer, and supplier of premium dietary supplement ingredients. The company offers a comprehensive portfolio of delivery forms including tri-layer and bi-layer tablets, extended-release/modified-release tablets, chewable and orally dispersible tablets (ODT), hard capsules, and customizable powders. The product portfolio is supported by proprietary technologies including taste & odor masking systems, beadlets, mini-tablets with personalized release technology, and Tablet-in-Capsule technology. US Pharma Lab specializes in probiotic-based supplements manufactured in dedicated controlled-environment facilities, along with solid food supplements and medical foods. The company provides complete turnkey operations including production and 12 dedicated packaging lines for bottles, cartons, blister cards, boxes, and stick packs.

Differentiator

Problem solved

Functional benefit

Products and services

• Custom Tablets (Tri-layer/Bi-layer, Extended-Release, Modified-Release, Chewable, ODT) Custom tablet development and manufacturing covering tri-layer and bi-layer constructions, extended- and modified-release profiles, plus chewable and orally dispersible tablet (ODT) formats for nutraceutical and dietary supplement brand customers.
• Hard Capsules Custom hard capsule manufacturing as one of USPL's core dosage formats for dietary supplement brands.
• Powder Formulations (Bulk, Ready-to-Drink, Customizable) Development and production of bulk powders, ready-to-drink powder formulations, and customizable powder products for supplement and functional-food customers.
• Beadlet Supplements Beadlet technology offering that enables delivery of actives in a beadlet form for dietary supplement brands seeking differentiated formats.
• Mini-Tablets with Personalized Release Technology Mini-tablet dosage format using USPL's personalized release technology for nutraceutical customers seeking precise, customizable release profiles.
• Probiotic Supplement Manufacturing Probiotic supplement manufacturing conducted in dedicated 25% relative humidity controlled rooms to protect probiotic viability and deliver reliable potency for brand customers.
• Solid Food Supplements Solid food-form supplement products offered as one of USPL's nine dosage formats for nutraceutical and functional food brands.
• Medical Foods Medical food products within USPL's portfolio, targeted at nutraceutical and clinical nutrition customers.
• Turnkey Packaging Solutions Complete turnkey packaging services designed to address product-development challenges for B2B customers, including execution alongside custom manufacturing programs.

Quantifiable outcome

• Global outreach spanning three continents

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Biofarma GroupcoreStrategic or Co-development Partner · 1 January 2023US Pharma Lab joined Biofarma Group in 2023, becoming part of a larger pharmaceutical manufacturing group with multiple manufacturing sites including facilities in Italy and France. The partnership provides USPL with enhanced global scale and resources while serving as Biofarma Group's North American headquarters and manufacturing hub.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Biofarma Group: Parent company and direct CDMO peer. Biofarma Group operates multiple manufacturing sites across Italy and France producing dietary supplements, probiotics, and medical foods using the same delivery-form technologies (mini-tablets, beadlets, ODT) and certifications. Most direct comparable because it shares product formats, customer base (supplement brands), and regulatory playbook.
• Glanbia Nutritionals: Provider of nutritional premixes, custom ingredient solutions, and finished supplement manufacturing for brand customers. Comparable to USPL's premix, ingredient supply, and contract manufacturing business, including customized formulations for supplement brands.
• Procaps Group: Latin American CDMO specializing in softgel, capsule, and tablet dietary supplement manufacturing for global brands. Comparable to USPL as a turnkey supplement contract manufacturer serving multinational brand clients with advanced delivery forms.
• Sirio Pharma: CDMO offering end-to-end development and manufacturing of dietary supplements including gummies, softgels, and probiotics. Comparable to USPL in turnkey contract manufacturing, probiotic capabilities, and serving supplement brand customers globally.

Broad incumbents

• Aenova Group: Large European CDMO offering solid, semi-solid, and liquid dosage forms for pharmaceuticals and dietary supplements. Comparable to USPL as a contract developer and manufacturer serving brand clients with turnkey operations and multi-format capabilities, though Aenova is broader in pharma.
• Catalent: Global CDMO with softgel, oral solid, and biologics capabilities serving pharma and consumer health. Overlaps with USPL in dietary supplement contract manufacturing, advanced oral dosage forms (including mini-tablet and modified-release technologies), and brand-client services.
• Lonza Capsules & Health Ingredients: Lonza operates a major capsules and health ingredients business including CDMO services for dietary supplements with beadlet and lipid-based delivery technology. Direct overlap with USPL's beadlet, capsule, and probiotic ingredient capabilities serving supplement brand customers.
• Recipharm: European-headquartered CDMO with solid dose and softgel capabilities for pharma and consumer health. Comparable to USPL in turnkey contract manufacturing of oral solid supplements and probiotics, though with a broader pharma mix.
• Delpharm: French CDMO with multiple sites producing solid dosage forms including dietary supplements and probiotics for brand clients. Comparable as a multi-site contract manufacturer offering turnkey supplement production with strong European regulatory footprint.
• Fareva: Global contract manufacturer with significant dietary supplement and probiotic capabilities across Europe and the Americas. Comparable to USPL in CDMO model, multi-format oral dose manufacturing, and probiotic specialization.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/us-pharma-lab
• Instagraminstagram.com/biofarmagroup
• Xx.com/uspharmalab

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about US Pharma Lab